Quantinno Capital Management LP Buys 35,835 Shares of Colgate-Palmolive (NYSE:CL)

Quantinno Capital Management LP lifted its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 25.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 176,609 shares of the company's stock after purchasing an additional 35,835 shares during the quarter. Quantinno Capital Management LP's holdings in Colgate-Palmolive were worth $18,334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of CL. Park Avenue Securities LLC raised its position in Colgate-Palmolive by 5.0% in the 2nd quarter. Park Avenue Securities LLC now owns 7,739 shares of the company's stock worth $751,000 after buying an additional 371 shares during the last quarter. CWM LLC raised its position in Colgate-Palmolive by 18.0% in the 2nd quarter. CWM LLC now owns 27,355 shares of the company's stock worth $2,655,000 after buying an additional 4,177 shares during the last quarter. Csenge Advisory Group raised its position in Colgate-Palmolive by 8.7% in the 2nd quarter. Csenge Advisory Group now owns 3,734 shares of the company's stock worth $362,000 after buying an additional 300 shares during the last quarter. Canandaigua National Bank & Trust Co. raised its position in Colgate-Palmolive by 3.2% in the 2nd quarter. Canandaigua National Bank & Trust Co. now owns 11,911 shares of the company's stock worth $1,156,000 after buying an additional 370 shares during the last quarter. Finally, BDF Gestion purchased a new position in Colgate-Palmolive in the 2nd quarter worth about $3,960,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of CL traded up $0.20 during midday trading on Thursday, hitting $95.01. 1,788,662 shares of the company traded hands, compared to its average volume of 4,372,648. The stock has a market cap of $77.62 billion, a price-to-earnings ratio of 27.17, a PEG ratio of 3.38 and a beta of 0.43. The firm has a 50 day moving average of $96.89 and a 200-day moving average of $98.63. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.11%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.34% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CL shares. Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their target price for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their price target for the company from $107.00 to $109.00 in a research report on Monday, September 9th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Finally, Piper Sandler began coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target for the company. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.